BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Protective effects of Lactococcus lactis subsp. lactis HFY14 supplementation on the brain, intestines, and motor function of antibiotic-treated mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1418556 Pub: 2024 Epub: 2024 Jun 14 Authors Yang Y , Zhao Y , Lei H , |
|
|
Dietary Supplementation of Lactococcus lactis subsp. lactis BIONCL17752 on Growth Performance, and Gut Microbiota of Broiler Chickens. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: Issue Pages: Pub: 2024 Jun 21 Epub: 2024 Jun 21 Authors Navale VD , Yadav R , Khilari A , Dharne M , Shanmugam D , Vamkudoth KR , |
|
|
Prophylactic effects of supplementation of a combination of Lactobacillus lactis WHH2078 and saffron on depressive-like behaviors in mice exposed to chronic stress. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 9 Pages: 5912-5927 Pub: 2024 Sep Epub: 2024 Aug 10 Authors Chen C , Zheng Z , Gao K , Fan Q , Li Y , Chen S , |
|
|
Synergistic activity of synbiotic blend between Lactococcus lactis KAFF 1-4 and fibersol-2 on gut microbiota modulation and anti-VRE properties. ✅
Go to Publication ✅
3 Biotech (3 Biotech ) Vol: 15 Issue 5 Pages: 133 Pub: 2025 May Epub: 2025 Apr 17 Authors Sathitkowitchai W , Mok K , Udomsri P , Nitisinprasert S , Nakphaichit M , |
|
|
Synergistic activity of synbiotic blend between Lactococcus lactis KAFF 1-4 and fibersol-2 on gut microbiota modulation and anti-VRE properties. ✅
Go to Publication ✅
3 Biotech (3 Biotech ) Vol: 15 Issue 5 Pages: 133 Pub: 2025 May Epub: 2025 Apr 17 Authors Sathitkowitchai W , Mok K , Udomsri P , Nitisinprasert S , Nakphaichit M , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
